Gene therapy injection shows promise for leg pain and ulcers
NCT ID NCT00696124
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tested the safety of a gene therapy called VM202 in 12 people with critical limb ischemia, a severe form of leg artery disease causing pain and ulcers. Participants received injections into their leg muscles and were monitored for side effects and pain relief over a year. The goal was to see if the treatment is safe enough for further testing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CRITICAL LIMB ISCHEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Minneapolis Heart Institute Foundation/ Abbott Northwestern Hospital
Minneapolis, Minnesota, 55407, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple thermal camera spot blood flow changes in leg arteries?
- Can Metal-Stripping infusions save diabetic limbs and hearts?
- Heat therapy for leg pain study pulled before starting
- New dissolving scaffold could save legs from amputation
- New imaging tool may predict leg amputation risk
- Music as medicine: simple tunes may soothe wound pain in artery disease